Khaitan & Co advised Alembic on the transaction.Alembic executed the acquisition of balance 40% stake in Aleor, a joint venture company of Alembic and Orbicular Pharmaceutical Technologies…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
